Loading quotes...
Forecast
The analysts' average price target is 101,98€ (+1,37%). The median is 104,67€ (+4,05%).
| Buy |
9 |
| Hold |
18 |
| Sell |
5 |
News Go to news feed
Aflac stock under pressure after ex-dividend dip and Wolfe 'underperform'
Aflac shares fell about 0.6% in premarket trading to $121.02 after the ex-dividend date for the quarterly dividend of $0.61 per share. Additional pressure came from Wolfe Research’s downgrade to “Underperform” with a $103 price target—implying roughly 15% downside—and from a partial share sale by Japan Post Holdings. Analysts point to a slowing core business in Japan, EPS supported by buyback-driven growth, and weak Q2 results, leaving Aflac’s Japan strategy and capital allocation under continued scrutiny. » More on de.investing.com
Aflac reaches record high of $122.93
Aflac shares rose to an all-time high of $122.93 and delivered a total return of 22.59% over the past year. Valuation metrics show a P/E ratio of 13.85 and a low PEG of 0.37, while InvestingPro rates the stock slightly above its fair-value estimate. For Q1 2026, Aflac reported revenue of $4.35 billion (expectation $4.18 billion); adjusted EPS was $1.75, just below the $1.80 estimate. The company highlights its strong dividend track record (42 consecutive years of increases) and operational initiatives such as opening an office in South Portland, Maine. » More on de.investing.com
Aflac hits record high of $120.30
Aflac shares rose to a record high of $120.30 and are trading just above the 52-week high; market capitalization is about $61.15 billion. Year-to-date the stock delivered a total return of 16.9%, the P/E ratio is 13.64 and the dividend yield 2.06% after 42 consecutive years of dividend increases. For Q1 2026 adjusted EPS missed estimates slightly at $1.75 versus $1.80 expected, while revenue of $4.35 billion comfortably beat expectations. One analysis rates the stock as slightly overvalued; shareholders approved nearly all proposals and the company is opening an office in South Portland to administer a paid family and medical leave program. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 3.58b | 0,03% |
| Gross profit | 1.95b | 94,77% |
| Net profit | 722.87m | 42,24% |
| EBITDA | 927.91m | 33,05% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | 51.29b€ |
Number of shares | 508.99m |
52-week high/low | 111,73€ - 89,80€ |
Dividend yield | 2,03% |
Dividends TTM | 2,04€ |
Next dividend | 0,52€ |
Beta | 0,6 |
P/E ratio | 12,60 |
PEG ratio | 0,11 |
P/B ratio | 1,95 |
P/S ratio | 3,31 |
Company profile
Aflac Incorporated bietet über ihre Tochtergesellschaften zusätzliche Kranken- und Lebensversicherungsprodukte an. Das Unternehmen ist in zwei Segmenten tätig: Aflac Japan und Aflac U.S. Das Segment Aflac Japan bietet in Japan Krebs-, Kranken-, Pflegegeld-, GIFT-, Voll- und Risikolebensversicherungen sowie WAYS- und Kinderausstattungspläne im Rahmen von Sparprodukten an. Das Segment Aflac U.S. bietet in den Vereinigten Staaten Krebs-, Unfall-, Kurzzeitinvaliditäts-, Critical-Illness-, Krankenhausentschädigungs-, Zahn-, Sehkraft-, Langzeitpflege- und Invaliditäts- sowie Risiko- und Volllebensversicherungsprodukte an. Das Unternehmen vertreibt seine Produkte über Vertriebsmitarbeiter, Makler, unabhängige Unternehmensagenturen, Einzelagenturen und angeschlossene Unternehmensagenturen. Das Unternehmen wurde 1955 gegründet und hat seinen Sitz in Columbus, Georgia.
| Name | AFLAC |
| CEO | Daniel Paul Amos |
| Headquarters | Columbus,
ga USA |
| Website | |
| Sector | Financials |
| Industry | Insurance |
| IPO | 03/17/1980 |
| Employees | 12.716 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | AFL |
London Stock Exchange | 0H68.L |
XETRA | AFL.DE |
Frankfurt | AFL.F |
Düsseldorf | AFL.DU |
Hamburg | AFL.HM |
London | 0H68.L |
SIX | AFL.SW |
München | AFL.MU |
Wien | AFL.VI |
Discover assets
Shareholders of AFLAC also invest in the following assets